The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares ...
The U.S. Food and Drug Administration has declined to approve Aldeyra Therapeutics' treatment for dry eye disease, the ...
Altria Group (NYSE: MO) stock was as popular as a used cigarette on Wednesday. The veteran tobacco company saw its share ...
The U.S. Supreme Court on Wednesday largely backed the Food and Drug Administration (FDA) in a case filed over its decision ...
Tobacco giant Altria Group has stopped selling its NJOY Ace e-cigarettes, after the U.S. International Trade Commission sided with rival Juul Labs in a patent dispute. Consumers can still buy them in ...
The departure comes just days after the FDA’s top vaccine official stepped down over disagreements with health secretary ...
The Food and Drug Administration said on Thursday that it would delay by 30 months a requirement that food companies and grocers rapidly trace contaminated food through the supply chain and pull ...
The administration delayed the move, set to take effect next year, for 30 months. By Christina Jewett The Food and Drug Administration said on Thursday that it would delay by 30 months a ...
Joseph Borzelleca published a study on red dye No. 3, a petroleum-based food coloring. The FDA cited his work to ban the ...
The Food and Drug Administration (FDA) examined the available evidence for harm from tartrazine but did not find it adequate. The FDA has approved the use of tartrazine in small quantities in certain ...
In my last analysis for Altria Group (NYSE:MO) stock, I recommended a BUY rating for the stock. To be more explicit, on February 7, 2025, I published an article on MO titled "Altria Q4 ...
The Trump administration has cut over $1 billion in food programs that funded schools and food banks, impacting millions of children and local farmers. The move, part of broader federal spending ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results